12-24 Hours
ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন
Register
0 People recently viewed this
Nomopil 0.5
Incepta Pharmaceuticals Ltd.
Generic: Repaglinide
Safety Advices
বাংলা
English
UNSAFE
It is unsafe to consume alcohol with Nomopil 0.5.
CONSULT YOUR DOCTOR
Nomopil 0.5 may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
SAFE IF PRESCRIBED
Nomopil 0.5 is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Monitor the breastfed baby’s blood sugar during treatment with Nomopil 0.5
CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
CAUTION
Nomopil 0.5 should be used with caution in patients with severe kidney disease. Dose adjustment of Nomopil 0.5 may be needed. Please consult your doctor.
CAUTION
Nomopil 0.5 should be used with caution in patients with liver disease. Dose adjustment of Nomopil 0.5 may be needed. Please consult your doctor.
Use of Nomopil 0.5 is not recommended in patients with severe liver disease.
Medicine Overview of Nomopil 0.5 0.5mg Tablet
Introduction
Nomopil 0.5 is used to lower blood sugar levels in adults with type 2 diabetes mellitus. It is usually prescribed along with other diabetes medicines to achieve adequate blood sugar control. It also prevents serious complications of diabetes like kidney damage and blindness. Nomopil 0.5 is normally prescribed when diet and exercise alone or other medicines have not been enough to control your blood sugar level. It works best when taken before meals. The dose will depend on your condition, and blood sugar levels, but you should use it as advised by your doctor. You should take it regularly, at...
... Show moreUses of Nomopil 0.5
- Type 2 diabetes mellitus
Side effects of Nomopil 0.5
Common
- Joint pain
- Dizziness
- Back pain
- Diarrhea
- Flu-like symptoms
- Upper respiratory tract infection
How to use Nomopil 0.5
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Nomopil 0.5 is to be taken empty stomach.
How Nomopil 0.5 works
Nomopil 0.5 is an anti-diabetic medication. It increases the amount of insulin released by the pancreas which prevents blood glucose from rising very high after meals.
What if you forget to take Nomopil 0.5?
If you miss a dose of Nomopil 0.5, skip it and continue with your normal schedule. Do not double the dose.
Quick Tips
- For best results, take Nomopil 0.5 15 to 30 minutes before a meal.
- You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with Nomopil 0.5
- It may cause dizziness. Do not drive or do anything that requires mental focus until you know how Nomopil 0.5 affects you.
- It may cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
- Always carry some sugary food or fruit juice with you in case you experience hypoglycemic symptoms such as cold sweats, cool pale skin, tremor, and anxiety.
- Monitor your blood sugar levels regularly while you are taking this medicine.
- Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.
Brief Description
Indication
Type 2 DM
Administration
Take 15 minutes before meal; no more than 4 meals/day
Adult Dose
Oral
Type 2 diabetes mellitus
Adult: Usual initial dose: 0.5 mg before main meals.
Initial doses of 1 or 2 mg may be used in patients who have had previous hypoglycaemic treatment.
May adjust dose at intervals of 1-2 wk, up to 4 mg before meals.
Max dose: 16 mg daily.
Hepatic impairment: May require longer intervals between dosage adjustments.
Child Dose
Safety and efficacy not established
Renal Dose
Renal Impairment
CrCl 40-80 mL/minute: No adjustments necessary
CrCl 20-40 mL/minute: 0.5 mg with meals; titrate slowly and monitor
CrCl < 20 mL/minute: Data not available
Contraindication
Diabetic ketoacidosis; severe hepatic impairment, type 1 diabetes; hypersensitivity. Lactation.
Mode of Action
Repaglinide stimulates release of insulin from pancreatic beta-cells by inhibiting K efflux via closure of ATP regulated K channels. This results in depolarization of the cell and opening of voltage-dependent Ca channels, which increases influx of Ca into the beta cells and causes release of insulin.
Precaution
Myocardial infarction, coma, trauma during surgery, elderly, malnourished and debilitated patients. Hepatic or severe renal impairment. Pregnancy.
Side Effect
Hypoglycaemia, nausea, diarrhoea, constipation, vomiting, dyspepsia, arthralgia, sinusitis, rhinitis, back pain; rash, pruritus, urticaria; visual disturbances.
Interaction
Cytochrome P450 3A4 inducers eg. rifampicin, barbiturates and carbamazepine may increase repaglinide metabolism. NSAIDs and other highly protein bound drugs eg, salicylates, sulphonamides, phenylbutazone, oral anticoagulants and hydantoins may potentiate action of repaglinide. Ketoconazole, fluconazole, itraconazole and erythromycin may increase plasma conc of repaglinide. Antagonistic effect with drugs causing hyperglycaemia. Concurrent use with gemfibrozil may lead to enhanced and prolonged blood glucose lowering effect.
Potentially Fatal: Increased risk of myocardial infarction when used with isophane insulin.
ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন
Register
